Dr. Mar Tintoré, new director of the Multiple Sclerosis Centre of Catalonia

As of October 1st, Dr. Mar Tintoré Subirana is the new Director of the Multiple Sclerosis Centre of Catalonia (Cemcat), taking over from Dr. Xavier Montalban.

 

With a professional career spanning over three decades at Vall d'Hebron University Hospital, Dr. Tintoré is also a Section Head within the Neurology Department and previously served as the Clinical Lead at Cemcat.

 

In the academic sphere, she is a professor at the University of Vic and a collaborating professor at the Autonomous University of Barcelona. An internationally renowned leader, she served as President of ECTRIMS (2022–2024) and co-chair of its 2025 congress in Barcelona, ​​which brought together over ten thousand multiple sclerosis experts. She is currently a member of the Clinical Trials Committee (ECTRIMS and NMSS) regarding the disease's diagnostic criteria, serves on the board of the European Charcot Foundation, and is President of the Scientific Advisory Board of EME (Multiple Sclerosis Spain).

 

Dr. Tintoré is also a principal investigator at VHIR and—alongside other Cemcat members—is recognized as a highly cited author (ranking in the top 1% of Clarivate Highly Cited Authors), with over 360 original scientific papers and review articles to her name. Her primary research focuses on therapeutic safety (infections and vaccination), care for elderly patients and vulnerable populations, early prognostic factors, the improvement of diagnostic criteria, women's health and family planning, and pediatric multiple sclerosis.

 

Cemcat is part of the Vall d'Hebron Barcelona Hospital Campus.